Skip to search.
 FTSE 100 Down 0.58%

AbbVie Inc. (ABBV)

-NYSE
57.65 Up 0.38(0.66%) 27 Mar 20:00
|After Hours: : 57.71 Up 0.06 (0.10%) 27 Mar 23:43
Add to Portfolio
Prev Close:57.27
Open:57.44
Bid:57.53 x 100
Ask:57.91 x 200
1y Target Est:69.08
Beta:1.66
Earnings Date:23 Apr - 27 Apr (Est.)
Day's Range:57.31 - 58.05
52wk Range:45.50 - 70.76
Volume:6,830,106
Avg Vol (3m):11,538,500
Market Cap:91.89b
P/E (ttm):52.41
EPS (ttm):1.10
Div & Yield:2.04 (3.50%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.66%91.89b
MRKUp 0.26%163.91b
NVSUp 0.84%240.82b
PFEUp 1.08%211.63b

Key Statistics

Forward P/E (1 yr):11.69
P/S (ttm):4.57
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :4.32
Quarterly EPS Est (Mar-15) :0.85
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):0.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback